Victor Mwapasa Selected Research

dolutegravir

1/2024	Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
1/2023	Erratum for Banda et al., "Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV".
12/2022	Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV.
1/2022	Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Mwapasa Research Topics

Disease

48	Malaria 04/2024 - 04/2004
13	Infections 01/2024 - 04/2004
10	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2020 - 04/2004
6	Birth Weight (Birth Weights) 01/2020 - 08/2005
6	HIV Infections (HIV Infection) 10/2019 - 06/2004
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 01/2020
4	Coinfection 12/2021 - 03/2009
3	Tuberculosis (Tuberculoses) 04/2024 - 01/2018
3	Nausea 01/2024 - 01/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2024 - 01/2017
2	Stillbirth 01/2020 - 01/2018
2	Pregnancy Complications 01/2018 - 11/2017
2	Vomiting 03/2016 - 01/2016
2	Asthenia 03/2016 - 01/2016
2	Dizziness (Lightheadedness) 03/2016 - 01/2016
2	Anemia 02/2011 - 03/2009
2	Hypoxia (Hypoxemia) 03/2008 - 08/2005
2	Chorioamnionitis 01/2006 - 08/2004
1	Cerebral Malaria 04/2024
1	Meningitis 04/2024
1	Encephalitis (Encephalitis, Rasmussen) 11/2023
1	Neoplasms (Cancer) 04/2022
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Premature Birth (Birth, Premature) 01/2020
1	Human Influenza (Influenza) 10/2019
1	Reinfection 05/2019
1	Obesity 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Neutropenia 11/2018
1	Thrombocytopenia (Thrombopenia) 11/2018
1	Parasitemia 02/2011

Drug/Important Bio-Agent (IBA)

17	piperaquineIBA 01/2024 - 01/2015
15	artenimol (dihydroartemisinin)IBA 01/2024 - 01/2015
13	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2024 - 12/2007
11	artemisinin (artemisinine)IBA 12/2022 - 01/2015
10	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 10/2021 - 01/2015
6	Antimalarials (Antimalarial Agents)IBA 03/2020 - 06/2004
6	AntibodiesIBA 10/2019 - 06/2004
5	VaccinesIBA 04/2024 - 12/2007
5	artesunate drug combination amodiaquineIBA 10/2021 - 01/2015
5	ArtesunateIBA 03/2019 - 01/2015
4	dolutegravirIBA 01/2024 - 01/2022
4	Mefloquine (Lariam)FDA LinkGeneric 03/2019 - 01/2015
4	Surface Antigens (Surface Antigen)IBA 03/2009 - 06/2004
3	Hemoglobins (Hemoglobin)IBA 01/2016 - 03/2009
3	Proteins (Proteins, Gene)FDA Link 03/2008 - 06/2004
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2024 - 02/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 09/2022 - 01/2018
2	Quinine (Quinson)FDA Link 01/2020 - 01/2020
2	Nevirapine (Viramune)FDA Link 08/2019 - 11/2018
2	efavirenz (Sustiva)FDA Link 08/2019 - 05/2019
2	Lumefantrine FDA Link 05/2019 - 11/2018
2	maleic acid (maleate)IBA 10/2017 - 04/2016
2	arterolaneIBA 10/2017 - 04/2016
2	Immunoglobulin G (IgG)IBA 01/2011 - 06/2004
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 09/2006
2	RNA (Ribonucleic Acid)IBA 01/2006 - 04/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2005 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005 - 08/2004
1	insulin receptor-related receptor (IRR)IBA 04/2024
1	Folic Acid AntagonistsIBA 01/2024
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2023
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2021
1	hemozoinIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2019
1	Interleukin-18 (Interleukin 18)IBA 10/2019
1	LeptinIBA 10/2019
1	EndoglinIBA 10/2019
1	AngiopoietinsIBA 10/2019
1	Chitinase-3-Like Protein 1IBA 10/2019
1	Carrier Proteins (Binding Protein)IBA 10/2019
1	C-Reactive ProteinIBA 10/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2019
1	SugarsIBA 01/2019
1	SaltsIBA 01/2019
1	FluoroquinolonesIBA 01/2018
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2018
1	symmetric dimethylarginineIBA 01/2018
1	AcidsIBA 01/2018
1	AgarIBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	Amodiaquine (Camoquin)FDA Link 01/2018
1	TabletsIBA 10/2017
1	LigandsIBA 01/2016
1	Sickle HemoglobinIBA 01/2016
1	Hemoglobin AIBA 01/2016
1	Sulfadoxine (Sulformethoxine)FDA Link 07/2014
1	Dihydropteroate Synthase (Dihydropteroate Synthetase)IBA 07/2014
1	AntigensIBA 12/2010
1	Complex MixturesIBA 11/2010

Therapy/Procedure

21	Therapeutics 01/2023 - 08/2004
4	Prenatal Care (Care, Prenatal) 01/2020 - 09/2008
2	Chemoprevention 01/2024 - 03/2020
2	Art Therapy 08/2019 - 05/2019
2	Aftercare (After-Treatment) 05/2019 - 11/2010
1	Self-Testing 04/2022
1	Condoms (Condom) 01/2022
1	Cryotherapy (Therapy, Cold) 04/2021
1	Behavior Control 01/2020